0001562180-21-003139.txt : 20210504
0001562180-21-003139.hdr.sgml : 20210504
20210504163421
ACCESSION NUMBER: 0001562180-21-003139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210430
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Donovan Joanne M.
CENTRAL INDEX KEY: 0001644087
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 21889082
MAIL ADDRESS:
STREET 1: C/O CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQ. BLDG. 1400E SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O ORBIMED ADVISORS LLC
STREET 2: 601 LEXINGTON AVE, 54TH FLR.
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-739-6451
MAIL ADDRESS:
STREET 1: C/O ORBIMED ADVISORS LLC
STREET 2: 601 LEXINGTON AVE, 54TH FLR.
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-04-30
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001644087
Donovan Joanne M.
C/O EDGEWISE THERAPEUTICS, INC.
3145 COLORADO AVE
BOULDER
CO
80303
false
true
false
false
CMO
Stock Option (Right to Buy)
28.64
2021-04-30
4
A
false
160000.00
0.00
A
2031-04-30
Common Stock
13964.00
160000.00
D
1/4th of the shares subject to the option will become vested and exercisable on April 26, 2022 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
John R. Moore Attorney-in-Fact for Donovan Joanne M.
2021-05-04